Literature DB >> 10760726

Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva.

D C Shugars1, G D Slade, L L Patton, S A Fiscus.   

Abstract

OBJECTIVE: The purpose of this investigation was to quantify human immunodeficiency virus type-1 (HIV-1) RNA in saliva and plasma and identify factors associated with increased salivary viral load. STUDY
DESIGN: Forty HIV-1-seropositive adults underwent oral examinations to assess mucosal and periodontal health. Whole saliva was evaluated for HIV-1 RNA titer and occult blood. Plasma viral load, CD4 cell count, HIV-1 staging, and antiretroviral therapy data were obtained from medical records. Associations between salivary titers and oral/systemic parameters were analyzed by means of t tests, Wilcoxon signed rank tests, Pearson's correlation coefficient, and analysis of covariance.
RESULTS: Forty-two percent of the subjects had detectable salivary HIV-1 RNA. Oral titers were highly correlated with plasma viral levels (r = 0.51, P <.01). HIV-associated periodontal disease (in particular, linear gingival erythema), severe gingival inflammation, and absence of antiretroviral therapy were associated with high salivary titers (P <.01).
CONCLUSIONS: Substantial quantities of HIV-1 can be shed in the oral cavity, particularly when inflammatory conditions are present. Salivary titer may be a useful indicator of systemic viral burden.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760726     DOI: 10.1016/s1079-2104(00)70124-7

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  13 in total

1.  Oral and systemic health correlates of HIV-1 shedding in saliva.

Authors:  M Navazesh; R Mulligan; N Kono; S K S Kumar; M Nowicki; M Alves; W J Mack
Journal:  J Dent Res       Date:  2010-07-29       Impact factor: 6.116

2.  Characterization of SIV in the oral cavity and in vitro inhibition of SIV by rhesus macaque saliva.

Authors:  Jessica S Thomas; Nedra Lacour; Pamela A Kozlowski; Steve Nelson; Gregory J Bagby; Angela M Amedee
Journal:  AIDS Res Hum Retroviruses       Date:  2010-08       Impact factor: 2.205

3.  Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments.

Authors:  R N Shepard; J Schock; K Robertson; D C Shugars; J Dyer; P Vernazza; C Hall; M S Cohen; S A Fiscus
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

4.  Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses.

Authors:  S A Freel; J M Williams; J A Nelson; L L Patton; S A Fiscus; R Swanstrom; D C Shugars
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.

Authors:  Shamim H Kazmi; Julian R Naglik; Simon P Sweet; Robert W Evans; Siobhan O'Shea; Jangu E Banatvala; Stephen J Challacombe
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

6.  Short chain fatty acids potently induce latent HIV-1 in T-cells by activating P-TEFb and multiple histone modifications.

Authors:  Biswajit Das; Curtis Dobrowolski; Abdel-Malek Shahir; Zhimin Feng; Xiaolan Yu; Jinfeng Sha; Nabil F Bissada; Aaron Weinberg; Jonathan Karn; Fengchun Ye
Journal:  Virology       Date:  2014-11-14       Impact factor: 3.616

7.  HIV shedding in the oral cavity: an assessment of HIV type, immunovirologic, demographic and oral factors.

Authors:  Patricia B Pavlinac; Stephen E Hawes; Geoffrey S Gottlieb; Awa Gaye; Charlotte F N'Diaye; Cathy W Critchlow; Papa Salif Sow; Qinghua Feng; Nancy B Kiviat
Journal:  Sex Transm Infect       Date:  2012-02       Impact factor: 3.519

Review 8.  Behavioral and biomedical combination strategies for HIV prevention.

Authors:  Linda-Gail Bekker; Chris Beyrer; Thomas C Quinn
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

9.  Monitoring HIV vaccine trial participants for primary infection: studies in the SIV/macaque model.

Authors:  James B Whitney; Corinne Luedemann; Saran Bao; Ayako Miura; Srinivas S Rao; John R Mascola; Norman L Letvin
Journal:  AIDS       Date:  2009-07-31       Impact factor: 4.177

10.  Detection of HIV-1 in Saliva: Implications for Case-Identification, Clinical Monitoring and Surveillance for Drug Resistance.

Authors:  Maya Balamane; Mark A Winters; Sudeb C Dalai; Alexandra H Freeman; Mark W Traves; Dennis M Israelski; David A Katzenstein; Jeffrey D Klausner
Journal:  Open Virol J       Date:  2010-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.